Cefoperazone, a new semisynthetic cephalosporin, has a broad spectrum of antibacterial activity. It is as active as cefazolin and cefamandole against grampositive bacteria and is more active than cefazolin and cefamandole against such gram-negative bacilli as Escherichia coli, Klebsiella pneumoniae, Proteus species, Pseudomonas aeruginosa, Citrobacter freundii, Enterobacter cloacae, and Serratia marcescens. The superiority of cefoperazone over cefazolin and cefamandole with respect to activity against P. aeruginosa by more than 200-fold was especially remarkable. As with other,8-lactam antibiotics, there was only a small spread between the minimum inhibitory concentrations and the minimum bactericidal concentrations of cefoperazone and a significant decrease in activity with an increase in inoculum size. Activity was not altered significantly by the addition of human serum to the test medium. Cefoperazone is relatively stable to hydrolysis to ,8-lactamases produced by gram-negative bacteria. Relative rates of hydrolysis of cefoperazone by cephalosporinases are 7.0 to 0.01, with reference to cephaloridine hydrolysis (base, 100). Cefoperazone is also more stable than penicillin G and cephaloridine to various types of penicillinases.
of 7 [D(-)-a-(4-ethyl-2,3-dioxo-1-piperadine-carboxamide) -a -(4 -hydroxyphenyl)acetamido] -3 -[(1-methyl-lH-tetra zol-5-yl)thiomethyl]-3-cephem-4-carboxylate ( Fig. 1) , has a broader spectrum of activity than related cephalosporins, including cefamandole (CMD) and cefazolin (CEZ) and is significantly active against Pseudomonas aeruginosa, Serratia marcescens, and Enterobacter cloacae. The current report summarizes our observations on the in vitro antibacterial activity of this new cephalosporin and its stability to 8i-lactamases.
MATERIALS AND METHODS
Antibiotics. CPZ was synthesized in the Research Laboratory of Toyama Chemical Co., Ltd., Toyama, Japan. CMD, CEZ, cephalothin, cephalexin, cephaloridine, carbenicillin (CB-PC), ampicillin, penicillin G, and gentamicin were obtained commercially.
Strains. The strains of gram-positive and gramnegative bacteria used in this study were isolated from clinical materials in Japan in 1972 to 1977 and have been maintained since isolation in the Reference Laboratory of Resistant Bacteria, School of Medicine, Gunma University.
Media. The heart infusion agar and brain heart infusion broth were products of Eiken Chemical Co., Ltd., and Difco Laboratories, respectively. Other media prepared locally included: peptone broth (10 g of polypeptone, 5 g of NaCl, and 1,000 ml of distilled water), medium B [2 g of yeast extract, 10 g of polypeptone, 8 g of Na2HPO4. 12H20, 2 g of KH2PO4, 1.2 g of (NH4)2S04, 2 g of glucose, and 0.4 g of MgSO4. 7H20 in 1,000 ml of distilled water], and nutrient broth (10 g of beef extract, 12 g of polypeptone, and 5 g of NaCl in 1,000 ml of distilled water). Peptone broth for the preculture of P. aeruginosa strains contained 0.3% KNO3 to yield a homogeneous culture.
Determination ofMICs. Minimum inhibitory concentrations (MICs) were determined by a serial dilution technique. Overnight cultures of test strains in peptone broth were diluted to a final concentration of about 10' cells per ml, and one loopful (0.005 ml) of each culture was spread on the heart infusion agar plates with an inoculator (Microplanter, Sakuma, Tokyo). MICs were determined after overnight incubation at 37°C. The effects of inoculum size on MICs were examined by a serial dilution technique via which the heart infusion agar plates were inoculated with 0.005 ml of cultures diluted to about 104, 106, and 108 cells per ml. The effects of human serum on MICs were investigated by a serial dilution method with the heart infusion agar containing 0, 10, and 40% pooled human serum (Consera, Nissui Pharmaceutical Co., Ltd., Tokyo).
Bactericidal activity. Correlation between the MIC and the minimum bactericidal concentration (MBC) was examined as follows. An 370C. One loopful (0.005 ml) of each culture tube, after determination of MICs, was seeded onto antibioticfree heart infusion agar plates and incubated overnight at 370C. The lowest concentration of antibiotic that inhibited visible growth on these plates was recorded as the MBC. For evaluation of bactericidal activity, an overnight culture in nutrient broth was diluted to 104 cells per nil with the same fresh medium and incubated with shaking at 370C. After growth to about 10' cells per ml, antibiotics were added to the cultures, and numbers of viable cells were counted at 2-h intervals.
Stability to ,f-lactamase. A 20-ml preculture of each strain in brain heart infusion broth was inoculated in 200 ml of medium B and shaken for 3 h at 370C. Cephalosporinase-producing strains, except (4, 14) , CEZ (6, 8, 9) , and CB-PC (1, 3) . Antibacterial activity of the drugs against all species tested is shown by the concentrations of the drugs required to inhibit the growth of 50, 75, and 90% of the total number of tested strains, that is, the MICso, the MIC75, and the MICso, respectively ( Table 1 (Fig. 3) . Against E. coli GN6307, CPZ was bactericidal at a concentration of 0.2 jog/ml, whereas CEZ was bactericidal at a concentration of 3.1 ,ug/ml. Against K. pneumoniae GN5558, these drugs were bactericidal at concentrations of 0.8 and 3.1 ,ug/ml, respectively, at the MIC of each drug. Against P. aeruginosa GN6736, CPZ was bactericidal at a concentration of 25 ,ug/ml, and CB-PC was bactericidal at a-concentration of 400 ,ug/ml. The killing effects of both drugs against each of the test organisms were complete at 4 h.
Stability to fi-lactamasp. CPZ was stable to ,8-lactamase produced by various species of gram-negative bacilli (Table 4) . CPZ was 100 to 10,000 times more stable than cephaloridine to cephalosporinases, except cephalosporinase produced by Proteus vulgaris (12, 15) . The stability of CPZ against type I, II, and IV penicilhinases mediated by R plasmids and penicillinase produced by K. pneumoniae was also examined (2, 7, 11, 16 
